ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
자궁내 이분척추 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 예상 성장률은 임신 중 진단 및 치료에 대한 인식 향상, 최소 침습적 수술 방법의 확산, 정부 지원 및 자금 투입 증가, 신흥 시장에서의 의료 인프라 확장, 전문 태아 수술 센터의 증가 등에 기인합니다. 이 기간의 주요 트렌드에는 임신 중 선별 검사 및 진단 기술의 발전, 최소 침습적 수술 기술의 기술 혁신, 태아 수술용 생체 재료 개발, 양수 기반 치료법 혁신, 태아 발달 지원을 위한 인공 자궁 기술 채택 등이 포함됩니다.
의료 시설의 확장은 이분척추 태아 시장 확대를 주도할 것으로 예상됩니다. 의료 시설은 효과적인 의료 서비스를 제공하기 위해 필요한 필수 인프라, 시스템, 자원을 의미합니다. 의료 인프라의 확장은 주로 원격의료, 로봇 수술, AI 기반 진단 등 의료 기술의 발전에 기인합니다. 이러한 기술들은 환자 결과와 효율성을 향상시키기 위해 최신 시설, 전문 장비, 개선된 의료 제공 시스템이 필요합니다. 이러한 의료 시설은 증거 기반 치료법, 숙련된 의료 전문가, 혁신적인 치료 옵션에 대한 접근을 보장함으로써 이분척추 태아 치료를 지원하며, 이는 환자의 치유 결과와 삶의 질을 개선합니다. 예를 들어, 미국에 본사를 두고 있는 비영리 단체인 미국 병원 협회(American Hospital Association)는 2024년 미국 내 병원 수가 2022년의 6,093개에서 6,120개로 증가했다고 보고했습니다.
자궁내 이분척추 시장에서 사업을 전개하는 기업은 첨단 영상 기술과 최소 침습적 기술을 결합한 수술 센터 등 혁신적인 센터 설립에 집중하고 있습니다. 수술 센터는 입원 없이 외래 환자 대상으로 수술을 수행하는 전문 시설로, 병원 입원 필요성을 제거합니다. 예를 들어, 2025년 1월 인도에 위치한 와디아 병원은 개방성 이분척추에 대한 태아 수술을 제공하는 센터를 개소했습니다. 이 시설은 최신 수술 기술과 다학제적 접근 방식을 통합해 조기 개입을 가능하게 하며, 이는 해당 질환으로 고통받는 영아의 합병증을 줄이고 장기적 예후를 개선할 수 있습니다. 이 센터는 수술의 정밀성과 고품질 환자 관리를 강조하며, 개방성 이분척추으로 어려움을 겪는 가족들에게 희망을 제공하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 자궁내 이분척추 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 자궁내 이분척추 시장 : 성장률 분석
세계의 자궁내 이분척추 시장 실적 : 규모와 성장(2019-2024년)
세계의 자궁내 이분척추 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 자궁내 이분척추전체 시장 규모(TAM)
제6장 시장 세분화
세계의 자궁내 이분척추 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
척수 수막류
수막류
은폐형
세계의 자궁내 이분척추 시장 : 진단별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
초음파
자기 공명 영상법(MRI)
양수 천자
세계의 자궁내 이분척추 시장 : 치료별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
수술
산후 수술
약물 관리
세계의 자궁 내 이분척추 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
외래수술센터(ASC)
세계의 자궁내 이분척추 시장 : 유형별 세분화, 척수 수막류, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
개방성 척수 수막류
폐쇄성 척수 수막류
요추-천추 척수 수막류
흉부 척수 수막류
경부 척수 수막류
세계의 자궁내 이분척추 시장 : 유형별 세분화, 수막류, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
두개 수막류
척수 수막류
후두 수막류
전두 수막류
두정부 수막류
세계의 자궁내 이분척추 시장 : 유형별 세분화, 은폐형, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
요추-천추 이분척추 은폐형
천골 이분척추 은폐형
고립성 이분척추 은폐형
복잡성 이분척추 은폐형
고정 척수 증후군 관련 은폐형
제7장 지역별 및 국가별 분석
세계의 자궁내 이분척추 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 자궁내 이분척추 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
자궁 내 이분척추 시장 : 경쟁 구도
자궁 내 이분척추 시장 : 기업 프로파일
Mayo Clinic : 개요, 제품 및 서비스, 전략 및 재무 분석
GE HealthCare : 개요, 제품 및 서비스, 전략 및 재무 분석
UC San Francisco : 개요, 제품 및 서비스, 전략 및 재무 분석
Children's Health : 개요, 제품 및 서비스, 전략 및 재무 분석
Memorial Hermann Health System : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Oregon Health & Science University
Seattle Children's
Texas Children's
Children's Hospital of Philadelphia
UW Health
UC Davis
UCSF Health
Burjeel Hospital
UT Physicians
Thieme Group
Riley Children's Health
Yale Medicine
Focused Ultrasound Foundation
Petals Health
Brown University Health
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
자궁내 이분척추 시장(2029년) : 새로운 기회를 제공하는 국가
자궁 내 이분척추 시장(2029년) : 새로운 기회를 제공하는 부문
자궁 내 이분척추 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Spina bifida in-utero refers to a prenatal surgical procedure aimed at repairing spina bifida, a neural tube defect in which the spine and spinal cord fail to develop properly. Performed before birth, this surgery helps reduce complications such as hydrocephalus, enhances mobility, and improves neurological outcomes. By closing the defect early, it protects the exposed spinal cord from further damage, ultimately improving the child's quality of life compared to postnatal repair.
The primary types of spina bifida in-utero include myelomeningocele, meningocele, and occulta. Myelomeningocele is the most severe form, characterized by the protrusion of the spinal cord and meninges through an opening in the spine. Diagnosis methods include ultrasound, magnetic resonance imaging (MRI), and amniocentesis. Treatment options consist of in-utero surgery, postnatal surgery, and medication management. These interventions are utilized in various healthcare settings, including hospitals, specialty clinics, and ambulatory surgical centers.
The spina bifida in-utero market research report is one of a series of new reports from The Business Research Company that provides spina bifida in-utero market statistics, including spina bifida in-utero industry global market size, regional shares, competitors with a spina bifida in-utero market share, detailed spina bifida in-utero market segments, market trends and opportunities, and any further data you may need to thrive in the spina bifida in-utero industry. This spina bifida in-utero market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The spina bifida in utero market size has grown strongly in recent years. It will grow from $2.42 billion in 2024 to $2.66 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the rising prevalence of spina bifida, increased awareness of fetal surgery, higher maternal age and associated pregnancy risks, growing healthcare expenditures, and advancements in research and development within fetal medicine.
The spina bifida in utero market size is expected to see strong growth in the next few years. It will grow to $3.77 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The projected growth during the forecast period can be attributed to rising awareness of prenatal diagnosis and treatment, greater adoption of minimally invasive procedures, increased government initiatives and funding, the expansion of healthcare infrastructure in emerging markets, and the growing number of specialized fetal surgery centers. Key trends for this period include advancements in prenatal screening and diagnostics, technological innovations in minimally invasive surgical techniques, the development of biomaterials for fetal surgery, innovations in amniotic fluid-based therapies, and the adoption of artificial womb technology to support fetal development.
The growth of healthcare facilities is expected to drive the expansion of the spina bifida in-utero market. Healthcare facilities refer to the essential infrastructure, systems, and resources required to provide effective medical services. The expansion of healthcare infrastructure is primarily attributed to advancements in medical technology, such as telemedicine, robotic surgery, and AI-driven diagnostics, all of which require updated facilities, specialized equipment, and improved healthcare delivery systems to enhance patient outcomes and efficiency. These healthcare facilities support spina bifida in-utero by ensuring access to evidence-based therapies, skilled medical professionals, and innovative treatment options, all of which improve healing outcomes and quality of life for patients. For example, the American Hospital Association, a US-based non-profit organization, reported that the total number of hospitals in the United States reached 6,120 in 2024, a rise from 6,093 hospitals in 2022. This growth in healthcare infrastructure is thus contributing to the development of the spina bifida in-utero market.
Companies operating in the spina bifida in-utero market are focusing on establishing innovative centers, such as surgery centers, that incorporate advanced imaging and minimally invasive techniques for fetal interventions. Surgery centers are specialized facilities where surgical procedures are performed on an outpatient basis, eliminating the need for hospital admission. For instance, in January 2025, Wadia Hospital, located in India, opened a center offering fetal surgery for open spina bifida. The facility integrates state-of-the-art surgical techniques and a multidisciplinary approach to enable early intervention, which can reduce complications and improve long-term outcomes for infants affected by the condition. The center emphasizes surgical precision and high-quality patient care, offering hope for families dealing with the challenges of open spina bifida.
In March 2024, Lilavati Hospital, an India-based multi-specialty healthcare institution, formed a partnership with the Medical University of Silesia. This collaboration aims to establish a fetal surgery department to provide advanced in-utero treatment for birth defects, including spina bifida. The Medical University of Silesia, located in Poland, is known for its expertise in fetal surgery techniques and in-utero treatments for various conditions.
Major players in the spina bifida in-utero market are Mayo Clinic, GE HealthCare, UC San Francisco, Children's Health, Memorial Hermann Health System, Oregon Health & Science University, Seattle Children's, Texas Children's, Children's Hospital of Philadelphia, UW Health, UC Davis, UCSF Health, Burjeel Hospital, UT Physicians, Thieme Group, Riley Children's Health, Yale Medicine, Focused Ultrasound Foundation, Petals Health, Brown University Health.
North America was the largest region in the spina bifida in utero market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in spina bifida in-utero report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the spina bifida in-utero market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The spina bifida in-utero market consists of revenues earned by entities providing services such as physical therapy planning, genetic counseling, and multidisciplinary team support. The market value includes the value of related goods sold by the service provider or included within the service offering. The spina bifida in-utero market also includes sales of sales of anesthesia and maternal support equipment, fetal monitoring devices, and biodegradable adhesives and sealants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Spina Bifida In-Utero Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on spina bifida in-utero market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for spina bifida in-utero ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spina bifida in-utero market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Myelomeningocele; Meningocele; Occulta
2) By Diagnosis: Ultrasound; Magnetic Resonance Imaging (MRI); Amniocentesis
3) By Treatment: Surgery; Postnatal Surgery; Medication Management
4) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers
Sub Segments:
1) By Myelomeningocele Type: Open Myelomeningocele; Closed Myelomeningocele; Lumbosacral Myelomeningocele; Thoracic Myelomeningocele; Cervical Myelomeningocele
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Spina Bifida In-Utero Market Characteristics
3. Spina Bifida In-Utero Market Trends And Strategies
4. Spina Bifida In-Utero Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Spina Bifida In-Utero Growth Analysis And Strategic Analysis Framework
5.1. Global Spina Bifida In-Utero PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Spina Bifida In-Utero Market Growth Rate Analysis
5.4. Global Spina Bifida In-Utero Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Spina Bifida In-Utero Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Spina Bifida In-Utero Total Addressable Market (TAM)
6. Spina Bifida In-Utero Market Segmentation
6.1. Global Spina Bifida In-Utero Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Myelomeningocele
Meningocele
Occulta
6.2. Global Spina Bifida In-Utero Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ultrasound
Magnetic Resonance Imaging (MRI)
Amniocentesis
6.3. Global Spina Bifida In-Utero Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Surgery
Postnatal Surgery
Medication Management
6.4. Global Spina Bifida In-Utero Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
6.5. Global Spina Bifida In-Utero Market, Sub-Segmentation Of Myelomeningocele Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Open Myelomeningocele
Closed Myelomeningocele
Lumbosacral Myelomeningocele
Thoracic Myelomeningocele
Cervical Myelomeningocele
6.6. Global Spina Bifida In-Utero Market, Sub-Segmentation Of Meningocele Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cranial Meningocele
Spinal Meningocele
Occipital Meningocele
Frontal Meningocele
Parietal Meningocele
6.7. Global Spina Bifida In-Utero Market, Sub-Segmentation Of Occulta Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lumbosacral Spina Bifida Occulta
Sacral Spina Bifida Occulta
Isolated Spina Bifida Occulta
Complex Spina Bifida Occulta
Tethered Cord Syndrome Associated Occulta
7. Spina Bifida In-Utero Market Regional And Country Analysis
7.1. Global Spina Bifida In-Utero Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Spina Bifida In-Utero Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
